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Dear Editor
In adults, central airway obstruction (CAO) 
can occur due to several benign and malignant 
etiologies either due to an endobronchial growth 
or extrinsic compression [1]. Mediastinal neo-
plasms may cause significant CAO due to extrin-
sic compression, and the clinical presentation is 
often accompanied by respiratory distress. Air-
way stenting is a well-established method for 
the immediate relief of symptoms as well as the 
restoration of airway patency in extrinsic lesions 
[1, 2]. Y-shaped self-expandable metallic stents 
(Y-SEMS) are commonly utilized in the manage-
ment of malignant airway obstruction [3, 4]. The 
placement of SEMS in malignant CAO is usually 
with palliative intent with the expectation that 
the stent provides symptomatic relief during 
the expected duration of survival of the patient. 
SEMS, once deployed, are rarely removed in 
malignant CAO. Here, we describe a case where 
we were able to successfully remove a metallic 
stent in a patient treated for malignant airway 
obstruction following chemotherapy.
A 45-year-old male patient presented with 
a history of facial swelling for 15 days associated 
with voice hoarseness and rapidly worsening re-
spiratory distress for two days. A chest radiograph 
(Figure 1A) revealed a well-defined homogenous 
opacity in the right paratracheal region. A CT scan 
of the thorax (Figure 1B and 1C) demonstrated 
a large heterogenous mediastinal mass encasing 
the superior vena cava causing narrowing of the 
lower trachea and bilateral proximal bronchi. 
A diagnostic flexible bronchoscopy examination 
with a pediatric bronchoscope revealed critical 
narrowing in the mid trachea. Because of rap-
idly worsening symptomatic CAO with a likely 
malignant etiology, a rigid bronchoscopy was 
performed under general anesthesia. A tracheo-
bronchial Y SEMS (Ottomed, 18 mm × 60 mm) 
was deployed successfully and tracheobronchial 
luminal patency was restored. The patient had 
immediate relief of symptoms. Subsequently, 
a CT guided percutaneous biopsy of the medias-
tinal mass was performed and was suggestive of 
Non-Hodgkin’s Lymphoma, B cell immune-phe-
notype (CD20+, BCL 6+). The patient was started 
on chemotherapy (CHOP-R regimen) and kept 
under close follow-up with serial radiographs and 
bronchoscopic examinations. After the 2nd cycle, 
the chest radiograph was suggestive of regression 
of the mass and the tracheobronchial lumen was 
seen entirely (Figure 1D). As the patient had clin-
ical and radiological improvement, stent removal 
was planned. Rigid bronchoscopy was performed 
under general anesthesia. The patient was intu-
bated with a size 12 mm tracheobronchoscope 
(Karl Storz, Germany), the proximal tracheal 
limb of the Y-SEMS was grasped with rigid stent 
placement forceps, gently twisted, and removed 
by proximal pulling. The stent was pulled into 
the lumen of the rigid bronchoscope with gradual, 
continuous rotating movements which separated 
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the stent from the tracheal wall. Subsequently, 
the retrieved stent, which was in the lumen of 
the rigid bronchoscope, was removed fully along 
with the bronchoscope. A flexible bronchosco-
py examination following removal of the stent 
showed minimal granulation tissue in the right 
main bronchus with complete luminal patency 
of the distal segments. The patient completed the 
chemotherapy cycles and was free of respiratory 
symptoms.  
Long-term placement of airway SEMS may 
be associated with a complication such as gran-
ulation tissue formation, and the incidence of 
complications such as these increases over time. 
Metal stents often incite exuberant granulation 
tissue growth which itself can lead to obstruc-
tion at either end of the stent. Because of the 
risk of stent-associated airway complications, it 
is generally advised that airway stent insertion 
should be considered as a last option (some 
authors comment that the best stent is one that 
was never placed). Of the available stents (SEMS 
and Silicon), advantages of SEMS include ease of 
placement (may be performed under conscious 
sedation using a flexible bronchoscope), lower 
incidence of migration, and better adaption to 
irregular and compressed airways. Disadvantag-
es of SEMS include possible complications like 
formation of granulation tissue, stent obstruction, 
fracture, erosion into surrounding tissue, and bac-
terial colonization. Lemaire et al. retrospectively 
reviewed the use of SEMS in a single institution 
and reported complications in 23 of 172 stent 
placements for malignant airway obstruction 
(tumor growth in nine, excessive granulation 
in seven, stent migration in five, and restenosis 
in two) [5]. These complications may require 
stent removal. Stent removal in the setting of 
stent-associated complications is difficult and 
potentially hazardous to the patient. Their re-
moval can induce further serious complications 
such as a mucosal tear, hemorrhage, retained 
stent fragments, pneumothorax, re-obstruction, 
and ventilation failure in severe cases. In a sin-
Figure 1. A. Baseline chest radiograph showing a large right paratracheal mass with tracheal compression; B. and C. CT thorax (mediastinal win-
dow) demonstrating a large mediastinal mass causing compression of the lower trachea and proximal main bronchi; D. Chest radiograph following 
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gle-institution review of the placement of covered 
SEMS for benign airway disease, complications 
requiring stent removal were reported in 10 out 
of 39 patients [6]. Granulation tissue formation 
was the most common complication and required 
repeated interventions. 
In this patient, considering the clinical sce-
nario and urgency, Y-SEMS insertion was per-
formed. Placement of a silicone stent could have 
been an option, but the diagnosis of lymphoma 
was not known at the time of SEMS placement. 
At the same time, insertion of silicone Y stents 
has particular problems in significant airway ob-
struction, as in this patient. The silicone stent is 
technically difficult to place in a complex airway 
as it requires the negotiation of a large rigid bron-
choscope across the stenosis [7]. The advantage 
of a silicone stent is low granulation tissue and 
ease of removal if required.
In conclusion, the reversibility of the un-
derlying pathology and the potential for stent 
removal should be considered at the time of 
stent placement. This case highlights the role of 
SEMS placement and removal in a patient with 
suspected malignant airway obstruction in a clin-
ical situation where the underlying malignancy is 
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